Verrica Pharmaceuticals
VRCA
VRCA
64 hedge funds and large institutions have $133M invested in Verrica Pharmaceuticals in 2023 Q4 according to their latest regulatory filings, with 8 funds opening new positions, 24 increasing their positions, 15 reducing their positions, and 11 closing their positions.
New
Increased
Maintained
Reduced
Closed
more capital invested
Capital invested by funds: $ → $
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more ownership
Funds ownership: →
less funds holding
Funds holding: →
27% less first-time investments, than exits
New positions opened: 8 | Existing positions closed: 11
66% less call options, than puts
Call options by funds: $209K | Put options by funds: $620K
100% less funds holding in top 10
Funds holding in top 10: 1 → 0 (-1)
Holders
64
Holding in Top 10
–
Calls
$209K
Puts
$620K
Top Buyers
| 1 | +$15.1M | |
| 2 | +$7.66M | |
| 3 | +$791K | |
| 4 |
Morgan Stanley
New York
|
+$759K |
| 5 |
Deutsche Bank
Frankfurt Am Main Ge,
Germany
|
+$625K |
Top Sellers
| 1 | -$1.01M | |
| 2 | -$649K | |
| 3 | -$265K | |
| 4 |
Two Sigma Investments
New York
|
-$251K |
| 5 |
KCM
Kornitzer Capital Management
Shawnee Mission,
Kansas
|
-$183K |